Qiagen Holds Annual General Meeting of Shareholders

Qiagen shareholders approved authority for a capital repayment of up to $200 million at the June 24, 2026 annual meeting. * The authorized synthetic share repurchase includes a reverse stock split and a reduction in ordinary shares’ par value to €0.01. * Shareholders authorized purchases of the company’s own shares through December 24, 2027, and approved cancellation of company-held ordinary shares. * The Supervisory Board received authorization through December 24, 2027, to issue ordinary shares and financing preference shares and restrict pre-emptive rights. * Investors adopted the 2025 annual accounts and approved the dividend for 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qiagen NV published the original content used to generate this news brief on November 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

QGEN